Search

Your search keyword '"Fanale Daniele"' showing total 326 results

Search Constraints

Start Over You searched for: Author "Fanale Daniele" Remove constraint Author: "Fanale Daniele"
326 results on '"Fanale Daniele"'

Search Results

1. The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors

2. Scientific Communication and oncology – "The bridge between knowledge and patients"

3. Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer

4. Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints

5. Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window?

6. R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair

10. Cancer of Exocrine Pancreas

11. Gastric Cancer: Locoregional Disease : General Section. Locoregional Disease

12. Tumor Board and Molecular Tumor Board

13. Nutrition and Cancer

14. Hereditary Cancers and Genetics

15. Biomarkers

16. Tumor Biology and Natural History

17. Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?

19. Challenges and advances for the treatment of renal cancer patients with brain metastases: From immunological background to upcoming clinical evidence on immune-checkpoint inhibitors

20. Definition and management of colorectal polyposis not associated with APC/MUTYH germline pathogenic variants: AIFEG consensus statement

22. BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants?

24. Circular RNA in Exosomes

25. Hereditary Cancers and Genetics

26. Cancer of Exocrine Pancreas

27. Nutrition and Cancer

28. Tumor Board and Molecular Tumor Board

29. Gastric Cancer: Locoregional Disease

30. Biomarkers

32. Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: looking for new tumor biological fingerprints

39. Targeted Therapies in Melanoma

42. Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay

43. sj-docx-1-tam-10.1177_17588359231151845 – Supplemental material for Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay

46. Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?

47. Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer

49. Immunometabolic predictive factors in Merkel cell carcinoma (MCC) patients treated with avelumab.

50. Impact of Different Selection Approaches for Identifying Lynch Syndrome-Related Colorectal Cancer Patients: Unity Is Strength

Catalog

Books, media, physical & digital resources